Nature, ISSN 0028-0836, 07/2018, Volume 559, Issue 7713, pp. 269 - 273
Aberrant activation of innate immune pathways is associated with a variety of diseases. Progress in understanding the molecular mechanisms of innate immune...
SYNTHASE | 2ND-MESSENGER | CELLS | CYCLIC GMP-AMP | ACTIVATION | AICARDI-GOUTIERES SYNDROME | MULTIDISCIPLINARY SCIENCES | CGAS | SENSOR | CYTOSOLIC-DNA | AUTOIMMUNE-DISEASE | Cell Line | Small Molecule Libraries - analysis | Small Molecule Libraries - pharmacology | Golgi Apparatus - drug effects | Humans | Mice, Inbred C57BL | Lipoylation - drug effects | Small Molecule Libraries - metabolism | Hereditary Autoinflammatory Diseases - drug therapy | Small Molecule Libraries - chemistry | Hereditary Autoinflammatory Diseases - metabolism | Animals | Membrane Proteins - antagonists & inhibitors | Signal Transduction - drug effects | Protein Binding - drug effects | Golgi Apparatus - metabolism | Cysteine - metabolism | Mice | Binding Sites | Immune response | Interferon | Nucleotide sequencing | Observations | Health aspects | Methods | DNA sequencing | Target recognition | Disease | Palmitoylation | Amino acids | Intracellular signalling | Activation | Antagonists | Drug development | Kinases | Immunosuppressive agents | Proteins | Stimulators | Signal transduction | Pathways | Chemical bonds | Deoxyribonucleic acid--DNA | Lupus | Medical treatment | Pharmacology | Inflammation | Gene expression | Golgi apparatus | Molecular modelling | Inhibitors | Scientific imaging | Mass spectrometry
SYNTHASE | 2ND-MESSENGER | CELLS | CYCLIC GMP-AMP | ACTIVATION | AICARDI-GOUTIERES SYNDROME | MULTIDISCIPLINARY SCIENCES | CGAS | SENSOR | CYTOSOLIC-DNA | AUTOIMMUNE-DISEASE | Cell Line | Small Molecule Libraries - analysis | Small Molecule Libraries - pharmacology | Golgi Apparatus - drug effects | Humans | Mice, Inbred C57BL | Lipoylation - drug effects | Small Molecule Libraries - metabolism | Hereditary Autoinflammatory Diseases - drug therapy | Small Molecule Libraries - chemistry | Hereditary Autoinflammatory Diseases - metabolism | Animals | Membrane Proteins - antagonists & inhibitors | Signal Transduction - drug effects | Protein Binding - drug effects | Golgi Apparatus - metabolism | Cysteine - metabolism | Mice | Binding Sites | Immune response | Interferon | Nucleotide sequencing | Observations | Health aspects | Methods | DNA sequencing | Target recognition | Disease | Palmitoylation | Amino acids | Intracellular signalling | Activation | Antagonists | Drug development | Kinases | Immunosuppressive agents | Proteins | Stimulators | Signal transduction | Pathways | Chemical bonds | Deoxyribonucleic acid--DNA | Lupus | Medical treatment | Pharmacology | Inflammation | Gene expression | Golgi apparatus | Molecular modelling | Inhibitors | Scientific imaging | Mass spectrometry
Journal Article
Molecular Neurobiology, ISSN 0893-7648, 9/2016, Volume 53, Issue 7, pp. 4638 - 4658
Oxidative and nitrosative stress (O&NS) is causatively implicated in the pathogenesis of Alzheimer’s and Parkinson’s disease, multiple sclerosis, chronic...
Neurology | Chronic fatigue | Neurosciences | Oxidative and nitrosative stress | Biomedicine | Cytokines | Neurobiology | Depression | Inflammation | Metabolism | Cell Biology | S-PALMITOYLATION | ALZHEIMERS-DISEASE | DIETARY DOCOSAHEXAENOIC ACID | CHOLESTEROL DOMAIN FORMATION | ALPHA-LIPOIC ACID | NEUROSCIENCES | DOUBLE-BLIND | POLYUNSATURATED FATTY-ACIDS | FISH-OIL | CHRONIC-FATIGUE-SYNDROME | MYELIN PROTEOLIPID PROTEIN | Lipoylation - physiology | Oxidation-Reduction | Membrane Microdomains - metabolism | Humans | Nitrosative Stress - physiology | Oxidative Stress - physiology | Lipoylation - drug effects | Nervous System Diseases - drug therapy | Neuroimmunomodulation - physiology | Membrane Microdomains - immunology | Animals | Signal Transduction - drug effects | Membrane Microdomains - drug effects | Nervous System Diseases - metabolism | Signal Transduction - physiology | Cell Membrane - immunology | Cell Membrane - metabolism | Drug Delivery Systems - trends | Oxidative Stress - drug effects | Nervous System Diseases - immunology | Cell Membrane - drug effects | Neuroimmunomodulation - drug effects | Fatty Acids, Omega-3 - administration & dosage | Nitrosative Stress - drug effects | Proteins | Post-translational modification | Multiple sclerosis | Depression, Mental | Physiological aspects | Schizophrenia | Cellular signal transduction | Permeability | Fatty acids | Alzheimer's disease | Chronic fatigue syndrome | Neurophysiology | Oxidative stress | Fatigue | Mental depression | Index Medicus
Neurology | Chronic fatigue | Neurosciences | Oxidative and nitrosative stress | Biomedicine | Cytokines | Neurobiology | Depression | Inflammation | Metabolism | Cell Biology | S-PALMITOYLATION | ALZHEIMERS-DISEASE | DIETARY DOCOSAHEXAENOIC ACID | CHOLESTEROL DOMAIN FORMATION | ALPHA-LIPOIC ACID | NEUROSCIENCES | DOUBLE-BLIND | POLYUNSATURATED FATTY-ACIDS | FISH-OIL | CHRONIC-FATIGUE-SYNDROME | MYELIN PROTEOLIPID PROTEIN | Lipoylation - physiology | Oxidation-Reduction | Membrane Microdomains - metabolism | Humans | Nitrosative Stress - physiology | Oxidative Stress - physiology | Lipoylation - drug effects | Nervous System Diseases - drug therapy | Neuroimmunomodulation - physiology | Membrane Microdomains - immunology | Animals | Signal Transduction - drug effects | Membrane Microdomains - drug effects | Nervous System Diseases - metabolism | Signal Transduction - physiology | Cell Membrane - immunology | Cell Membrane - metabolism | Drug Delivery Systems - trends | Oxidative Stress - drug effects | Nervous System Diseases - immunology | Cell Membrane - drug effects | Neuroimmunomodulation - drug effects | Fatty Acids, Omega-3 - administration & dosage | Nitrosative Stress - drug effects | Proteins | Post-translational modification | Multiple sclerosis | Depression, Mental | Physiological aspects | Schizophrenia | Cellular signal transduction | Permeability | Fatty acids | Alzheimer's disease | Chronic fatigue syndrome | Neurophysiology | Oxidative stress | Fatigue | Mental depression | Index Medicus
Journal Article
Molecular Endocrinology, ISSN 0888-8809, 05/2012, Volume 26, Issue 5, pp. 762 - 774
The estrogen receptor-α (ERα) is a transcription factor that regulates gene expression through the binding to its cognate hormone 17β-estradiol (E2). ERα...
BREAST-CANCER CELLS | INTEGRIN-LINKED KINASE | CARCINOMA CELLS | PHOSPHORYLATION | PROTEASOME | ENDOCRINOLOGY & METABOLISM | MEDIATED DEGRADATION | PLASMA-MEMBRANE | BINDING | STEROID-RECEPTORS | ER-ALPHA | Acyltransferases - antagonists & inhibitors | Cell Line | Palmitic Acid - metabolism | Estrogens - pharmacology | Humans | Transcriptional Activation - drug effects | Enzyme Inhibitors - pharmacology | Lipoylation - drug effects | Presenilin-2 - metabolism | Cathepsin D - metabolism | RNA, Messenger - metabolism | Serine - metabolism | Response Elements - drug effects | Proteolysis - drug effects | Estrogen Receptor alpha - genetics | Protein Processing, Post-Translational - drug effects | Signal Transduction - drug effects | Palmitates - pharmacology | Presenilin-2 - genetics | Cathepsin D - genetics | Estrogen Receptor alpha - metabolism | Female | Phosphorylation - drug effects | Estradiol - pharmacology | Original Research
BREAST-CANCER CELLS | INTEGRIN-LINKED KINASE | CARCINOMA CELLS | PHOSPHORYLATION | PROTEASOME | ENDOCRINOLOGY & METABOLISM | MEDIATED DEGRADATION | PLASMA-MEMBRANE | BINDING | STEROID-RECEPTORS | ER-ALPHA | Acyltransferases - antagonists & inhibitors | Cell Line | Palmitic Acid - metabolism | Estrogens - pharmacology | Humans | Transcriptional Activation - drug effects | Enzyme Inhibitors - pharmacology | Lipoylation - drug effects | Presenilin-2 - metabolism | Cathepsin D - metabolism | RNA, Messenger - metabolism | Serine - metabolism | Response Elements - drug effects | Proteolysis - drug effects | Estrogen Receptor alpha - genetics | Protein Processing, Post-Translational - drug effects | Signal Transduction - drug effects | Palmitates - pharmacology | Presenilin-2 - genetics | Cathepsin D - genetics | Estrogen Receptor alpha - metabolism | Female | Phosphorylation - drug effects | Estradiol - pharmacology | Original Research
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 10/2015, Volume 125, Issue 10, pp. 3904 - 3914
Valproic acid (VPA) has been widely used for decades to treat epilepsy; however, its mechanism of action remains poorly understood. Here, we report that the...
MEDICINE, RESEARCH & EXPERIMENTAL | IN-VIVO MICRODIALYSIS | RAT HIPPOCAMPUS | KAINIC ACID | BIPOLAR DISORDER | PALMITOYLATED PROTEINS | SYNAPTIC PLASTICITY | POTASSIUM CHANNEL SUBUNITS | K+ CHANNELS | AKAP SIGNALING COMPLEXES | INDUCED SEIZURES | Muscarinic Agonists - pharmacology | Humans | Seizures - drug therapy | Male | KCNQ2 Potassium Channel - drug effects | Receptor, Muscarinic M1 - physiology | Anticonvulsants - pharmacology | Recombinant Fusion Proteins - metabolism | Valproic Acid - pharmacology | Recombinant Fusion Proteins - drug effects | Seizures - chemically induced | A Kinase Anchor Proteins - genetics | A Kinase Anchor Proteins - physiology | Seizures - physiopathology | Drug Interactions | Protein Processing, Post-Translational - drug effects | Receptor, Muscarinic M1 - drug effects | Muscarinic Antagonists - pharmacology | Female | Valproic Acid - therapeutic use | KCNQ2 Potassium Channel - physiology | Neurons - metabolism | Phosphorylation - drug effects | Kainic Acid - toxicity | Neurons - drug effects | A Kinase Anchor Proteins - metabolism | Action Potentials - drug effects | Potassium Channel Blockers - pharmacology | Carbamates - pharmacology | Mice, Inbred C57BL | Cells, Cultured | Lipoylation - drug effects | Anticonvulsants - therapeutic use | Rats | Hippocampus - cytology | Superior Cervical Ganglion - cytology | Anthracenes - pharmacology | Animals | Signal Transduction - drug effects | Recombinant Fusion Proteins - genetics | Phenylenediamines - pharmacology | Mice | Divalproex | Pharmacology, Experimental | Drug interactions | Dosage and administration | Potassium channels | Research | Valproic acid | Health aspects | Studies | Phosphorylation | Preservation | Epilepsy | Bipolar disorder | Kinases | Potassium | Experiments
MEDICINE, RESEARCH & EXPERIMENTAL | IN-VIVO MICRODIALYSIS | RAT HIPPOCAMPUS | KAINIC ACID | BIPOLAR DISORDER | PALMITOYLATED PROTEINS | SYNAPTIC PLASTICITY | POTASSIUM CHANNEL SUBUNITS | K+ CHANNELS | AKAP SIGNALING COMPLEXES | INDUCED SEIZURES | Muscarinic Agonists - pharmacology | Humans | Seizures - drug therapy | Male | KCNQ2 Potassium Channel - drug effects | Receptor, Muscarinic M1 - physiology | Anticonvulsants - pharmacology | Recombinant Fusion Proteins - metabolism | Valproic Acid - pharmacology | Recombinant Fusion Proteins - drug effects | Seizures - chemically induced | A Kinase Anchor Proteins - genetics | A Kinase Anchor Proteins - physiology | Seizures - physiopathology | Drug Interactions | Protein Processing, Post-Translational - drug effects | Receptor, Muscarinic M1 - drug effects | Muscarinic Antagonists - pharmacology | Female | Valproic Acid - therapeutic use | KCNQ2 Potassium Channel - physiology | Neurons - metabolism | Phosphorylation - drug effects | Kainic Acid - toxicity | Neurons - drug effects | A Kinase Anchor Proteins - metabolism | Action Potentials - drug effects | Potassium Channel Blockers - pharmacology | Carbamates - pharmacology | Mice, Inbred C57BL | Cells, Cultured | Lipoylation - drug effects | Anticonvulsants - therapeutic use | Rats | Hippocampus - cytology | Superior Cervical Ganglion - cytology | Anthracenes - pharmacology | Animals | Signal Transduction - drug effects | Recombinant Fusion Proteins - genetics | Phenylenediamines - pharmacology | Mice | Divalproex | Pharmacology, Experimental | Drug interactions | Dosage and administration | Potassium channels | Research | Valproic acid | Health aspects | Studies | Phosphorylation | Preservation | Epilepsy | Bipolar disorder | Kinases | Potassium | Experiments
Journal Article
EMBO Molecular Medicine, ISSN 1757-4676, 03/2018, Volume 10, Issue 3, p. n/a
Metabolic reprogramming is widely known as a hallmark of cancer cells to allow adaptation of cells to sustain survival signals. In this report, we describe a...
NSCLC | EGFR‐TKI | FASN | acquired resistance | palmitoylation | EGFR-TKI | MEDICINE, RESEARCH & EXPERIMENTAL | GEFITINIB | LIPID-METABOLISM | ORLISTAT | T790M MUTATION | DRUG-RESISTANCE | UBIQUITINATION | INHIBITION | GROWTH | EXPRESSION | CARCINOMA | Weight reducing preparations | Ubiquitin | Tyrosine | Epidermal growth factor | Synthesis | Physiological aspects | Lung cancer, Small cell | Lung cancer, Non-small cell | Fatty acids | Drug approval | Cell culture | Cell survival | Epidermal growth factor receptors | Small cell lung carcinoma | Tumor cells | Palmitoylation | Lung cancer | Non-small cell lung carcinoma | Lung carcinoma | Palmitic acid | Kinases | Fatty-acid synthase | Signal transduction | Ubiquitination | Protein-tyrosine kinase | Digestive System | Pharmacology & Drug Discovery | Cancer
NSCLC | EGFR‐TKI | FASN | acquired resistance | palmitoylation | EGFR-TKI | MEDICINE, RESEARCH & EXPERIMENTAL | GEFITINIB | LIPID-METABOLISM | ORLISTAT | T790M MUTATION | DRUG-RESISTANCE | UBIQUITINATION | INHIBITION | GROWTH | EXPRESSION | CARCINOMA | Weight reducing preparations | Ubiquitin | Tyrosine | Epidermal growth factor | Synthesis | Physiological aspects | Lung cancer, Small cell | Lung cancer, Non-small cell | Fatty acids | Drug approval | Cell culture | Cell survival | Epidermal growth factor receptors | Small cell lung carcinoma | Tumor cells | Palmitoylation | Lung cancer | Non-small cell lung carcinoma | Lung carcinoma | Palmitic acid | Kinases | Fatty-acid synthase | Signal transduction | Ubiquitination | Protein-tyrosine kinase | Digestive System | Pharmacology & Drug Discovery | Cancer
Journal Article
Biochemistry, ISSN 0006-2960, 04/2016, Volume 55, Issue 14, pp. 2135 - 2143
Members of the protein kinase C (PKC) family of serine/threonine kinases regulate various cellular functions, including cell growth, differentiation,...
TRANSLOCATION | ANTICANCER | MEMBRANE-STRUCTURE | BIOCHEMISTRY & MOLECULAR BIOLOGY | THERAPEUTIC TARGET | HEART-FAILURE | PKC-ALPHA | FATTY-ACIDS | ACTIVATOR BINDING DOMAIN | HYDROPHOBIC MOIETY | CANCER | Gene Expression Regulation, Enzymologic - drug effects | Curcumin - analogs & derivatives | Protein Kinase C-epsilon - chemistry | Antioxidants - chemistry | Cricetulus | Protein Kinase C-alpha - metabolism | Curcumin - chemistry | Protein Transport - drug effects | Protein Processing, Post-Translational - drug effects | Drug Design | Protein Kinase C-epsilon - antagonists & inhibitors | Phosphorylation - drug effects | Cell Membrane - drug effects | CHO Cells | Cell Survival - drug effects | Protein Kinase C-alpha - antagonists & inhibitors | Lipoylation | Curcumin - pharmacology | Antioxidants - pharmacology | Curcumin - adverse effects | Enzyme Activation - drug effects | Cell Membrane - enzymology | Microscopy, Confocal | Animals | MAP Kinase Signaling System - drug effects | Protein Kinase C-alpha - chemistry | Protein Kinase C-epsilon - metabolism | Antioxidants - adverse effects | Kinetics | Methylation
TRANSLOCATION | ANTICANCER | MEMBRANE-STRUCTURE | BIOCHEMISTRY & MOLECULAR BIOLOGY | THERAPEUTIC TARGET | HEART-FAILURE | PKC-ALPHA | FATTY-ACIDS | ACTIVATOR BINDING DOMAIN | HYDROPHOBIC MOIETY | CANCER | Gene Expression Regulation, Enzymologic - drug effects | Curcumin - analogs & derivatives | Protein Kinase C-epsilon - chemistry | Antioxidants - chemistry | Cricetulus | Protein Kinase C-alpha - metabolism | Curcumin - chemistry | Protein Transport - drug effects | Protein Processing, Post-Translational - drug effects | Drug Design | Protein Kinase C-epsilon - antagonists & inhibitors | Phosphorylation - drug effects | Cell Membrane - drug effects | CHO Cells | Cell Survival - drug effects | Protein Kinase C-alpha - antagonists & inhibitors | Lipoylation | Curcumin - pharmacology | Antioxidants - pharmacology | Curcumin - adverse effects | Enzyme Activation - drug effects | Cell Membrane - enzymology | Microscopy, Confocal | Animals | MAP Kinase Signaling System - drug effects | Protein Kinase C-alpha - chemistry | Protein Kinase C-epsilon - metabolism | Antioxidants - adverse effects | Kinetics | Methylation
Journal Article
Biochemical Society Transactions, ISSN 0300-5127, 08/2017, Volume 45, Issue 4, pp. 913 - 921
The Ras proteins are well-known drivers of many cancers and thus represent attractive targets for the development of anticancer therapeutics. Inhibitors that...
Acyltransferases - antagonists & inhibitors | Neoplasms - metabolism | ras Proteins - genetics | Hydrolysis - drug effects | Humans | ras Proteins - metabolism | Neoplasm Proteins - antagonists & inhibitors | Neoplasms - prevention & control | Antineoplastic Agents - therapeutic use | Protein Transport - drug effects | Acyltransferases - metabolism | Neoplasm Proteins - metabolism | Carcinogenesis - metabolism | Molecular Targeted Therapy - trends | Neoplasms - genetics | Protein Processing, Post-Translational - drug effects | Isoenzymes - metabolism | Thiolester Hydrolases - antagonists & inhibitors | Cysteine - metabolism | Neoplasm Proteins - genetics | Lipoylation - drug effects | Enzyme Activation - drug effects | Enzyme Inhibitors - therapeutic use | Neoplasms - drug therapy | Carcinogenesis - drug effects | Animals | Thiolester Hydrolases - metabolism | Mutation | Isoenzymes - antagonists & inhibitors
Acyltransferases - antagonists & inhibitors | Neoplasms - metabolism | ras Proteins - genetics | Hydrolysis - drug effects | Humans | ras Proteins - metabolism | Neoplasm Proteins - antagonists & inhibitors | Neoplasms - prevention & control | Antineoplastic Agents - therapeutic use | Protein Transport - drug effects | Acyltransferases - metabolism | Neoplasm Proteins - metabolism | Carcinogenesis - metabolism | Molecular Targeted Therapy - trends | Neoplasms - genetics | Protein Processing, Post-Translational - drug effects | Isoenzymes - metabolism | Thiolester Hydrolases - antagonists & inhibitors | Cysteine - metabolism | Neoplasm Proteins - genetics | Lipoylation - drug effects | Enzyme Activation - drug effects | Enzyme Inhibitors - therapeutic use | Neoplasms - drug therapy | Carcinogenesis - drug effects | Animals | Thiolester Hydrolases - metabolism | Mutation | Isoenzymes - antagonists & inhibitors
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 05/2013, Volume 288, Issue 21, pp. 14959 - 14972
The eukaryotic cell depends on multitiered homeostatic systems ensuring maintenance of proteostasis, organellar integrity, function and turnover, and overall...
IN-VITRO | UNFOLDED PROTEIN RESPONSE | INHIBITION | MOLECULAR CHAPERONES | AMINO-ACIDS | ER STRESS | BIOCHEMISTRY & MOLECULAR BIOLOGY | INCREASES | ENDOPLASMIC-RETICULUM STRESS | INDUCTION | CELL-DEATH | Caco-2 Cells | Heat-Shock Response - drug effects | Lipoylation - physiology | Microtubule-Associated Proteins - genetics | Microtubule-Associated Proteins - metabolism | Humans | Lipoylation - drug effects | Gene Expression Regulation - physiology | HSP70 Heat-Shock Proteins - genetics | Transcription Factors - biosynthesis | Autophagy - physiology | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Heat-Shock Response - physiology | Sirolimus - pharmacology | Autophagy - drug effects | Heat Shock Transcription Factors | Gene Expression Regulation - drug effects | Anti-Bacterial Agents - pharmacology | Mutation | DNA-Binding Proteins - biosynthesis | HSP70 Heat-Shock Proteins - biosynthesis | Exercise | mTOR | Akt | Autophagy | Protein Folding | Cell Biology | Heat Shock Protein
IN-VITRO | UNFOLDED PROTEIN RESPONSE | INHIBITION | MOLECULAR CHAPERONES | AMINO-ACIDS | ER STRESS | BIOCHEMISTRY & MOLECULAR BIOLOGY | INCREASES | ENDOPLASMIC-RETICULUM STRESS | INDUCTION | CELL-DEATH | Caco-2 Cells | Heat-Shock Response - drug effects | Lipoylation - physiology | Microtubule-Associated Proteins - genetics | Microtubule-Associated Proteins - metabolism | Humans | Lipoylation - drug effects | Gene Expression Regulation - physiology | HSP70 Heat-Shock Proteins - genetics | Transcription Factors - biosynthesis | Autophagy - physiology | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Heat-Shock Response - physiology | Sirolimus - pharmacology | Autophagy - drug effects | Heat Shock Transcription Factors | Gene Expression Regulation - drug effects | Anti-Bacterial Agents - pharmacology | Mutation | DNA-Binding Proteins - biosynthesis | HSP70 Heat-Shock Proteins - biosynthesis | Exercise | mTOR | Akt | Autophagy | Protein Folding | Cell Biology | Heat Shock Protein
Journal Article
Nature Chemical Biology, ISSN 1552-4450, 06/2010, Volume 6, Issue 6, pp. 449 - 456
Cycles of depalmitoylation and repalmitoylation critically control the steady-state localization and function of various peripheral membrane proteins, such as...
TRANSFORMATION | PATHWAYS | COMPLEX | PALMITOYLATION | ACYL-PROTEIN THIOESTERASE | CRYSTAL-STRUCTURE | PANCREATIC LIPASE | NATURAL-PRODUCT STRUCTURE | 2-BROMOPALMITATE | GOLGI | BIOCHEMISTRY & MOLECULAR BIOLOGY | Kidney - physiology | Propiolactone - analogs & derivatives | Propiolactone - chemical synthesis | Humans | ras Proteins - metabolism | Enzyme Inhibitors - chemical synthesis | Propiolactone - pharmacology | Enzyme Inhibitors - chemistry | Thiolester Hydrolases - antagonists & inhibitors | ras Proteins - drug effects | ras Proteins - physiology | Cell Line | Kidney - drug effects | Signal Transduction | Down-Regulation | Enzyme Inhibitors - pharmacology | Lipoylation - drug effects | Models, Molecular | Propiolactone - chemistry | Lipase - metabolism | Lipase - chemistry | Animals | Stomach - enzymology | Dogs | Ligands | Protein Conformation | Thiolester Hydrolases - genetics | Thiolester Hydrolases - chemistry | Cell division | Molecules | Inhibitor drugs | Genes
TRANSFORMATION | PATHWAYS | COMPLEX | PALMITOYLATION | ACYL-PROTEIN THIOESTERASE | CRYSTAL-STRUCTURE | PANCREATIC LIPASE | NATURAL-PRODUCT STRUCTURE | 2-BROMOPALMITATE | GOLGI | BIOCHEMISTRY & MOLECULAR BIOLOGY | Kidney - physiology | Propiolactone - analogs & derivatives | Propiolactone - chemical synthesis | Humans | ras Proteins - metabolism | Enzyme Inhibitors - chemical synthesis | Propiolactone - pharmacology | Enzyme Inhibitors - chemistry | Thiolester Hydrolases - antagonists & inhibitors | ras Proteins - drug effects | ras Proteins - physiology | Cell Line | Kidney - drug effects | Signal Transduction | Down-Regulation | Enzyme Inhibitors - pharmacology | Lipoylation - drug effects | Models, Molecular | Propiolactone - chemistry | Lipase - metabolism | Lipase - chemistry | Animals | Stomach - enzymology | Dogs | Ligands | Protein Conformation | Thiolester Hydrolases - genetics | Thiolester Hydrolases - chemistry | Cell division | Molecules | Inhibitor drugs | Genes
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 9/2015, Volume 112, Issue 38, pp. 11876 - 11880
Palmitoylation is the posttranslational modification of proteins with a 16-carbon fatty acid chain through a labile thioester bond. The reversibility of...
Fas | Calcium | Lck | Protein palmitoylation | Apoptosis | LOCALIZATION | COMPLEX | calcium | MULTIDISCIPLINARY SCIENCES | apoptosis | protein palmitoylation | LYSOPHOSPHOLIPASE | INHIBITION | T-CELL-ACTIVATION | CDNA CLONING | LYMPHOCYTES | Palmitic Acid - metabolism | Phospholipase C gamma - metabolism | Temperature | Apoptosis - drug effects | Calcium - metabolism | Jurkat Cells | Membrane Microdomains - metabolism | Humans | Lipoylation - drug effects | Lymphocyte Specific Protein Tyrosine Kinase p56(lck) - metabolism | Protein Transport - drug effects | Acyltransferases - metabolism | fas Receptor - metabolism | Egtazic Acid - pharmacology | Signal Transduction - drug effects | T-Lymphocytes - metabolism | Membrane Microdomains - drug effects | Intracellular Space - metabolism | Staining and Labeling | Egtazic Acid - analogs & derivatives | Enzyme Activation | HeLa Cells | Tyrosine | Post-translational modification | Influence | Research | Palmitoylation | Analysis | Biological Sciences
Fas | Calcium | Lck | Protein palmitoylation | Apoptosis | LOCALIZATION | COMPLEX | calcium | MULTIDISCIPLINARY SCIENCES | apoptosis | protein palmitoylation | LYSOPHOSPHOLIPASE | INHIBITION | T-CELL-ACTIVATION | CDNA CLONING | LYMPHOCYTES | Palmitic Acid - metabolism | Phospholipase C gamma - metabolism | Temperature | Apoptosis - drug effects | Calcium - metabolism | Jurkat Cells | Membrane Microdomains - metabolism | Humans | Lipoylation - drug effects | Lymphocyte Specific Protein Tyrosine Kinase p56(lck) - metabolism | Protein Transport - drug effects | Acyltransferases - metabolism | fas Receptor - metabolism | Egtazic Acid - pharmacology | Signal Transduction - drug effects | T-Lymphocytes - metabolism | Membrane Microdomains - drug effects | Intracellular Space - metabolism | Staining and Labeling | Egtazic Acid - analogs & derivatives | Enzyme Activation | HeLa Cells | Tyrosine | Post-translational modification | Influence | Research | Palmitoylation | Analysis | Biological Sciences
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2015, Volume 10, Issue 12, p. e0144648
Fatty acid synthase (FASN) catalyzes the de novo synthesis of palmitate, a fatty acid utilized for synthesis of more complex fatty acids, plasma membrane...
MICRODOMAINS | FUSION | ASSAY | INFECTED CELLS | MEMBRANE | MULTIDISCIPLINARY SCIENCES | F-PROTEIN | LIPID RAFTS | IN-VIVO | CANCER | CAVEOLIN-1 | Fatty Acid Synthase, Type I - genetics | Palmitic Acid - metabolism | Respiratory Mucosa - drug effects | Humans | Respiratory Mucosa - virology | Enzyme Inhibitors - chemical synthesis | Palmitic Acid - antagonists & inhibitors | Viral Proteins - metabolism | Parainfluenza Virus 3, Human - metabolism | Respiratory Syncytial Virus Infections - drug therapy | Respiratory Syncytial Virus Infections - virology | Respiratory Syncytial Viruses - metabolism | Parainfluenza Virus 3, Human - drug effects | Rhinovirus - drug effects | Virus Replication - drug effects | Antiviral Agents - pharmacology | Gene Expression | Administration, Oral | Respiratory Syncytial Viruses - drug effects | Enzyme Inhibitors - pharmacology | Lipoylation - drug effects | Respiratory Mucosa - enzymology | Viral Proteins - genetics | Viral Proteins - antagonists & inhibitors | Virion - metabolism | Fatty Acid Synthase, Type I - metabolism | Fatty Acid Synthase, Type I - antagonists & inhibitors | Hep G2 Cells | Virion - drug effects | Host-Pathogen Interactions | Animals | Parainfluenza Virus 3, Human - growth & development | Respiratory Syncytial Viruses - growth & development | Antiviral Agents - chemical synthesis | Rhinovirus - metabolism | Mice | Mice, Inbred BALB C | Protein Processing, Post-Translational | Rhinovirus - growth & development | HeLa Cells | Virion - growth & development | Respiratory tract infections | Care and treatment | Respiratory syncytial virus | Research | Diagnosis | Fatty acids | Risk factors | Cell culture | Membrane structure | Palmitoylation | Epithelial cells | Viruses | Lipids | Infections | Palmitic acid | Kinases | Proteins | Infectivity | Rodents | Antiviral activity | Post-translation | Inhibition | Chemical synthesis | Parainfluenza | Oral administration | Particulates | Membrane composition | Ribonucleic acid--RNA | Fatty-acid synthase | Progeny | Inhibitors | Lungs | Replication | RNA | Ribonucleic acid
MICRODOMAINS | FUSION | ASSAY | INFECTED CELLS | MEMBRANE | MULTIDISCIPLINARY SCIENCES | F-PROTEIN | LIPID RAFTS | IN-VIVO | CANCER | CAVEOLIN-1 | Fatty Acid Synthase, Type I - genetics | Palmitic Acid - metabolism | Respiratory Mucosa - drug effects | Humans | Respiratory Mucosa - virology | Enzyme Inhibitors - chemical synthesis | Palmitic Acid - antagonists & inhibitors | Viral Proteins - metabolism | Parainfluenza Virus 3, Human - metabolism | Respiratory Syncytial Virus Infections - drug therapy | Respiratory Syncytial Virus Infections - virology | Respiratory Syncytial Viruses - metabolism | Parainfluenza Virus 3, Human - drug effects | Rhinovirus - drug effects | Virus Replication - drug effects | Antiviral Agents - pharmacology | Gene Expression | Administration, Oral | Respiratory Syncytial Viruses - drug effects | Enzyme Inhibitors - pharmacology | Lipoylation - drug effects | Respiratory Mucosa - enzymology | Viral Proteins - genetics | Viral Proteins - antagonists & inhibitors | Virion - metabolism | Fatty Acid Synthase, Type I - metabolism | Fatty Acid Synthase, Type I - antagonists & inhibitors | Hep G2 Cells | Virion - drug effects | Host-Pathogen Interactions | Animals | Parainfluenza Virus 3, Human - growth & development | Respiratory Syncytial Viruses - growth & development | Antiviral Agents - chemical synthesis | Rhinovirus - metabolism | Mice | Mice, Inbred BALB C | Protein Processing, Post-Translational | Rhinovirus - growth & development | HeLa Cells | Virion - growth & development | Respiratory tract infections | Care and treatment | Respiratory syncytial virus | Research | Diagnosis | Fatty acids | Risk factors | Cell culture | Membrane structure | Palmitoylation | Epithelial cells | Viruses | Lipids | Infections | Palmitic acid | Kinases | Proteins | Infectivity | Rodents | Antiviral activity | Post-translation | Inhibition | Chemical synthesis | Parainfluenza | Oral administration | Particulates | Membrane composition | Ribonucleic acid--RNA | Fatty-acid synthase | Progeny | Inhibitors | Lungs | Replication | RNA | Ribonucleic acid
Journal Article